Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
about
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
@en
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
@nl
type
label
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
@en
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
@nl
prefLabel
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
@en
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
@nl
P2093
P2860
P1476
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.
@en
P2093
Alessandra Di Liberto
Luca Durelli
Marinella Clerico
Pierangelo Barbero
Stefania Federica De Mercanti
Valentina Bardina
P2860
P304
P356
10.1080/14740338.2017.1346082
P407
P577
2017-06-22T00:00:00Z